July 25, 2025 02:51 pm (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
Tejashwi Yadav mulls boycotting Bihar polls over SIR, says 'no point in holding elections when people can't vote' | 'EC can't escape': Rahul Gandhi slams poll body for 'cheating' amid uproar over SIR in Bihar | 'Perverse exercise of judicial power': SC slams Karnataka HC bail to actor Darshan in Renukaswamy murder case | Supreme Court stays Bombay HC order acquitting 12 people in Mumbai train bomb blasts case | ED raids Anil Ambani's 35 premises in Delhi and Mumbai for alleged money laundering | PM Modi embarks on visit to the UK and Maldives | 'Steeped in fanaticism and terrorism': India slams 'serial borrower' Pakistan at UN | 'We stopped India-Pakistan war': Donald Trump reiterates 'ceasefire' claim | Air India completes inspections of Fuel Control Switch on Boeing aircrafts after deadly Ahmedabad crash | Supreme Court refuses to stop QR code directive for eateries along Kanwar Yatra route
IPO

Mankind Pharma IPO to open on Apr 25

| @indiablooms | Apr 20, 2023, at 01:11 am

Mumbai/IBNS: Mankind Pharma Ltd will launch its initial public offering (IPO) of 40,058,844 equity shares on Tuesday, April 25, 2023, the company said on Wednesday.

The IPO will close on Thursday, April 27, 2023.

The anchor investor bidding date is on April 24, 2023, a day before the IPO date.

The price band of the offer has been fixed from Rs 1,026 per equity share to Rs 1,080 per equity share.

Bids can be made for a minimum of 13 equity shares and in multiples of 13 equity shares thereafter.

The company’s IPO is fully an offer for sale of 40,058,844 equity shares by its promoters and other shareholders.

At the upper band of the price range, the Delhi-based drug maker plans to raise around Rs 4,326.36 crore.

Those selling shares are promoters Ramesh Juneja, Rajeev Juneja and Sheetal Arora.

Further, investors Cairnhill CIPEF Ltd, Cairnhill CGPE Ltd, Beige Ltd and Link Investment Trust will also participate in the OFS.

Since the IPO is completely an OFS, any net proceeds from the issue and the entire net proceeds will go to the selling shareholders.

The equity shares offered through the red herring prospectus (RHP) are proposed to be listed on both BSE and NSE.

Kotak Mahindra Capital Company Ltd, Axis Capital Limited, IIFL Securities Limited, Jefferies India Private Limited, and J.P. Morgan India Private Limited the book-running lead managers to the issue.

Support Our Journalism

We cannot do without you.. your contribution supports unbiased journalism

IBNS is not driven by any ism- not wokeism, not racism, not skewed secularism, not hyper right-wing or left liberal ideals, nor by any hardline religious beliefs or hyper nationalism. We want to serve you good old objective news, as they are. We do not judge or preach. We let people decide for themselves. We only try to present factual and well-sourced news.

Support objective journalism for a small contribution.
Related Videos
RBI announces repo rate cut Jun 06, 2025, at 10:51 am
FM Nirmala Sitharaman presents Budget 2025 Feb 01, 2025, at 03:45 pm
Nirmala Sitharaman on Budget 2024 Jul 23, 2024, at 09:30 pm
Close menu